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Edward Y. Woo, MD, Omaida C. Velazquez, MD, Michael A. Golden, MD, and Jeffrey P. Carpenter,
MD, Philadelphia, Pa
Objective: Accessory renal arteries are frequently encountered when patients are evaluated for endovascular abdominal
aortic aneurysm repair (EVAR). Some have considered their presence a contraindication to EVAR in fear of endoleak and
the end result of renal function. We sought to determine whether the coverage of accessory renal arteries during EVAR
was associated with any adverse sequelae.
Methods: Retrospective review of the medical records and computed tomographic scans of all patients undergoing EVAR
(1998 to 2003) was performed. Note was made of the presence or absence of accessory renal arteries, hypertension, and
renal function. Preoperative computed tomographic images were compared with postoperative images to determine the
presence of renal infarction. A control group of 26 consecutive patients without accessory renal arteries was used for
comparison of the results of EVAR.
Results: EVAR was performed in 550 patients over the study interval. The mean follow-up was 16 months (range, 1-48
months). The average age was 74 years (range, 57-90 years). Thirty-five patients (6.6%; 32 male and 3 female) were
documented to have accessory renal arteries; the average number of accessory arteries was 2 (range, 1-4). Bilateral
accessory arteries were present in 13 patients: all but 1 patient (n 34) had a left-sided accessory renal artery, and 23 had
a right-sided accessory renal artery. EVAR was performed with a variety of endografts: AneuRx (n 10), Talent (n 7),
PowerLink (n  7), Zenith (n  5), LifePath (n  4), and Ancure (n  2). There were no mortalities. Twelve endoleaks
were documented: three type I, eight type II, and one type III. The accessory renal arteries were not implicated in any of
the endoleaks, and none of these accessory vessels was embolized before or after EVAR. Seven patients (20%) had renal
infarcts associated with EVAR that were noted on follow-up computed tomographic scans. The mean follow-up for
patients with segmental infarction was 23 months (range, 8-48 months). Hypertensive status did not change in any
patient in whom an accessory renal artery had been covered. The average serum creatinine was 1.08 mg/dL (range,
0.6-1.8 mg/dL) before EVAR in patients with accessory renal arteries covered by an endovascular graft and did not
change significantly in response to EVAR. Serum creatinine increased almost twofold in two patients but spontaneously
resolved in follow-up. The average preoperative creatinine clearance was 79mL/min (range, 35-166mL/min) in patients
without an accessory renal artery and was 80 mL/min (range, 35-167 mL/min) after EVAR. The average preoperative
creatinine clearance was 67 mL/min (range, 31-137 mL/min) in patients with an accessory renal artery and 68 mL/min
(range, 45-83 mL/min) in patients with renal infarcts. None of the patients required temporary or permanent dialysis.
There was no difference between control patients and patients with covered accessory renal arteries with respect to
hypertensive status, presence of renal infarcts, serum creatinine, or creatinine clearance after EVAR.
Conclusions: Occlusion of accessory renal arteries is not associated with clinically significant signs or symptoms, even in
patients with mild or moderate renal insufficiency. Sacrifice of accessory renal arteries most commonly does not lead to
detectable renal infarction, either clinically or radiographically. When segmental infarction of the kidney does result, it
seems to be well tolerated in this group of patients. Accessory renal arteries were not found to contribute to endoleaks and
should not be prophylactically embolized. (J Vasc Surg 2006;43:8-13.)Endovascular abdominal aortic aneurysm repair
(EVAR) is a valuable option in selected patients, with
acceptable morbidity and mortality rates.1 However, not all
cases are amendable for EVAR.2 Inadequate proximal neck,
tortuosity, and the size of iliac vessels dictate the operative
choice and the feasibility of abdominal stent grafts.
In addition, the presence of renal accessory arteries may
disfavor the placement of endovascular grafts in abdominal
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8aortic aneurysms for fear of renal infarction. Approximately
15% to 30% of all adult patients have renal accessory arter-
ies.3 The blood supply to the kidney is segmental with
functional end arteries, without adequate intraparenchymal
collateral arteries. Thus, thrombosis could lead to segmen-
tal infarction and worsening of renal function.
Supernumerary renal arteries or accessory arteries occur
commonly. They usually arise from the lateral aorta, with a
slightly higher frequency from the left than from the right
side.3 These may enter the parenchyma of the kidney through
one of its poles or through the renal hilum.More commonly,
when entering the parenchyma, they do so through the upper
pole. When they enter through the lower pole, they tend to
cross anteriorly to the inferior vena cava.
The clinical implications of lost renal function as a
direct result of exclusion of a renal accessory artery in a
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remain unknown. Medical literature is scarce in regard to
complications of segmental renal infarction. Theoretically,
the loss of renal parenchyma could lead to worsening of
renal function, as determined by an increase in plasma
creatinine or blood pressure. We sought to determine
whether coverage of the accessory renal arteries during
EVAR was associated with any adverse long-term sequelae.
METHODS
Retrospective review of the 550 consecutive medical
records and computed tomographic (CT) scans of all pa-
tients who underwent EVAR (1998 to 2003) was per-
formed. Note was made of the presence or absence of
accessory renal arteries by imaging studies. Accessory renal
arteries were defined as supernumerary renal arteries
smaller than and located below the main renal artery.
Supernumerary renal arteries located above the main renal
artery (and therefore not considered for coverage during
EVAR) were not included in the analysis. Patients’ medical
history of hypertension was reviewed, as was their renal
function. All CT scans were performed in a standard man-
ner. Initially non–contrast-enhanced images in 7.5 helical
collimation were performed. This was followed by a test
bolus of 16 mL of contrast. High-resolution CT angio-
grams (2.5-mm cuts) were performed, followed by 4 mL/s
intravenous contrast bolus administration of nonionic con-
trast per CT angiography protocol. A delayed postcontrast
examination of the abdomen and pelvis was performed in
5-mm collimation. Preoperative CT scans were compared
with postoperative images to determine the presence of
renal infarction. Patients were followed up initially at quar-
terly intervals and subsequently at annual intervals. At each
office visit, blood pressure was measured and recorded.
Clinical characteristics of patients with renal accessory
artery were compared with those of a series of consecutive
patients without renal accessory arteries (n 26). Statistical
analysis was performed by using the Student t test for paired
data, with a significance level of P  .05.
RESULTS
EVAR was performed in 550 patients over the study
interval (Table I). Of those screened for EVAR candidacy,
six were excluded from EVAR because of the presence of
supernumerary renal arteries that were thought to be essen-
tial.2 The mean follow-up was 16 months (range, 1-48
months). Thirty-five patients (6%; 32 male and 3 female)
were documented to have accessory renal arteries; the
average number of accessory arteries was 2 (range, 1-4).
Bilateral accessory arteries were present in 13 patients. All
but one patient (n  34) had a left-sided accessory renal
artery, and 23 had a right-sided accessory renal artery. The
average age was 74 years (range, 57-90 years).
In the control group, the average age was 74 years
(range, 61-86 years; Table II). All 26 patients had infrare-
nal fixation by using the unibody bifurcated graft (Power-
Link; Endologix Inc, Irvine, Calif). Five control patients
(19%) had small renal infarcts in association with EVAR onfollow-up CT scans. The average preoperative blood pres-
sure in this control group was 131/93 mm Hg (range,
systolic 93-205 mm Hg, diastolic 55-114 mm Hg; Table
III). The average blood pressure on follow-up was 151/85
mm Hg (range, 108-211 over 55-114 mm Hg). The
average preoperative blood pressure in patients with seg-
mental renal infarction (in the control group) was 145/69
mm Hg (range, 101-205 over 60-109 mm Hg) and on
follow-up was 159/92 mm Hg (range, 150-211 over 73-
114 mm Hg). Two patients in this control group had
pre-existing high systolic blood pressure. Their hyperten-
sive status remained unchanged after EVAR. Significant
differences in serum creatinine values were not appreciated
after EVAR for patients in the control group (Table III).
The average preoperative serum creatinine was 1.1 (range,
0.7-1.8) and on follow-up was 1.06 (range, 0.6-1.8; not
significant). The average preoperative creatinine in patients
who developed segmental renal infarcts was 1.42 (range,
Table I. Characteristics of 35 EVAR patients* with
accessory renal arteries
Clinical characteristic n
Sex
Male 32
Female 3
Renal infarcts associated with EVAR 7
Mortality 0
Average number of renal accessory arteries 2
Patients with bilateral accessory renal arteries 13
Left-sided accessory renal artery 34
Right-sided accessory renal artery 23
Type of endovascular graft
AneuRx 10
Talent 7
PowerLink 7
Zenith 5
LifePath 4
Ancure 2
Endoleak
Type I 3
Type II 8
Type III 1
Type IV 0
Accessory arteries implicated in endoleak 0
EVAR, Endovascular abdominal aortic aneurysm repair.
*Mean age was 74 years.
Table II. Characteristics of 26 EVAR patients* without
accessory renal arteries (control group)
Clinical characteristic n
Sex
Male 24
Female 2
Renal infarcts associated with EVAR 2
Mortality 0
EVAR, Endovascular abdominal aortic aneurysm repair.
*Mean age was 74 years.1.1-1.8), and the creatinine level was 1.1 (range, 1.1-1.8)
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in two patients and did not change on follow-up. The
average preoperative creatinine clearance was 79 mL/min,
and after surgery it was 80 mL/min. The preoperative
creatinine clearance in the control group that developed
renal infarcts was 68mL/min (range, 35-91mL/min), and
creatinine clearance was 66 mL/min (range, 35-91 mL/
min) on follow-up.
EVARwas performedwith a variety of endografts in the
patients with covered accessory renal arteries: AneuRx
(Medtronic, Minneapolis, MN) (n  10), Talent
(Medtronic, Minneapolis, MN) (n  7), PowerLink (En-
dologix, Inc, Irvine, Calif) (n  7), Zenith (COOK,
Bloomington, Ind) (n  5), LifePath (Edwards Life-
sciences, Corp, Irvine, Calif) (n  4), and Ancure
(Guidant, Menlo Park, Calif) (n  2). There were no
mortalities. Twelve endoleaks were documented in follow-
up: three type I, eight type II, and one type III. The
accessory renal arteries were not implicated in any of the
endoleaks, and none of these accessory vessels required
embolization before or after EVAR. All accessory renal
arteries thrombosed after coverage (Fig 1). Seven patients
(20%) had renal infarcts associated with EVAR on fol-
low-up CT scans (Fig 2). The mean follow-up for patients
with segmental infarction was 23 months (range, 8-48
months).
Hypertensive status did not change in association with
renal segmental infarction or in any patient in whom an
accessory renal artery had been covered (Table II). The
average preoperative blood pressure in our 35 patients was
142/76 mm Hg (range, 119-180 over 62-96 mm Hg).
The average blood pressure on follow-up was 140/74 mm
Hg (range, 106-172 over 56-96 mm Hg). The average
blood pressure in patients with segmental renal infarction
before surgery was 151/72 mm Hg (range, 136-170 over
62-90 mm Hg) and on follow-up was 147/67 mm Hg
(range, 102-170 over 56-75 mmHg). Two patients in our
series had pre-existing high systolic blood pressure. Their
hypertensive status remained unchanged after EVAR.
Table III. Effect of accessory renal artery (RA) coverage o
Variable Preop
Serum creatinine
Accessory RA (n  35) 1.08
Control group (n  26) 1.1
Accessory RA with renal infarcts (n  7) 1.15
Control group with renal infarcts (n  5) 1.4
Creatinine clearance (mL/min)
Accessory RA (n  35) 67
Control group (n  26) 79
Accessory RA with renal infarcts (n  7) 63
Control group (n  5) 68
Hypertensive status (mm Hg)
Accessory RA (n  35) 142/76
Control group (n  26) 131/93
Accessory RA with renal infarcts (n  7) 151/72
Control group with renal infarcts (n  5) 145/69There was no difference between accessory renal artery andcontrol patients with respect to hypertensive status or
blood pressure before or after EVAR.
Significant differences in serum creatinine values were
not appreciated after EVAR for patients with covered ac-
cessory renal arteries (Table III). The average preoperative
serum creatinine was 1.08 (range, 0.6-1.8), and on fol-
low-up it was 1.11 (range, 0.6-1.8; P .1; not significant).
The average postoperative creatinine in patients who devel-
oped segmental renal infarcts was 1.05 (range, 0.9-2.7).
Serum creatinine increased almost twofold in two patients
but spontaneously resolved in follow-up. There were no
nical outcome parameters
ve mean (range) Postoperative mean (range)
1.8) 1.11 (0.6-1.8)
1.8) 1.06 (0.6-1.8)
1.6) 1.28 (0.9-2.7)
1.8) 1.1 (1-1.8)
137) 67 (25-141)
166) 80 (35-167)
83) 68 (45-83)
91) 66 (35-106)
-180 over 62-96) 140/74 (106-172 over 56-96)
205 over 55-114) 151/85 (108-211 over 55-114)
-170 over 62-90) 147/67 (102-170 over 56-75)
-205 over 60-109) 159/92 (150-211 over 73-114)
Fig 1. Coverage of accessory renal arteries during endovascular
abdominal aortic aneurysm repair leads to their thrombosis. A,
Preoperative computed tomographic angiography (CTA) with an
accessory right renal artery (arrow). B, Postoperative CTA dem-
onstrating accessory renal artery thrombosis.n cli
erati
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EVAR.
Both preoperative and postoperative creatinine clear-
ance were 67 mL/min (range, 25-141 mL/min) in pa-
tients with renal accessory arteries. Similarly, creatinine
clearance did not change significantly for control patients
after EVAR (Table III). There were no differences between
accessory renal artery and control patients with respect to
creatinine clearance before and after EVAR.
DISCUSSION
EVAR is an evolving surgical technique. However,
secure fixation and seal within the proximal neck continue
to be a challenge. A generally accepted requisite is the
presence of an adequate proximal neck length (15 mm).
Many patients do not fulfill this criterion and are excluded.2
A relative contradiction to EVAR is the presence of acces-
sory renal arteries, which would be covered by the stent
graft. In our prior report2 of patients excluded for EVAR,
we noted six patients whom we excluded from EVAR
candidacy on the basis of the “presence of accessory renal
arteries.” In this former article, we excluded these patients
from EVAR because of the presence of supernumerary
renal arteries in a configuration such that the main renal
artery would of necessity be covered during EVAR. In our
present study of 550 EVAR patients, 35 patients had cov-
erage of accessory renal arteries. All of these patients had
supernumerary renal arteries, but in a configuration such
that the smaller accessory arteries, rather than the main
renal artery, were covered during EVAR. Although seven
patients developed renal infarcts, as documented by post-
operative CT scans, there was no significant change in the
renal function or hypertensive status of these patients, and
there were no differences between patients with covered
accessory renal arteries and controls.
The long-term clinical implication of excluding the
accessory renal arteries is not fully known. With findings
Fig 2. Segmental renal infarction resulting from accessory renal
artery coverage during endovascular abdominal aortic aneurysm
repair.similar to our own, Aquino et al4 reviewed 311 patientstreated with EVAR for abdominal aortic aneurysms. They
documented 24 patients with covered accessory renal arter-
ies, using the Ancure device in 23 patients and the Excluder
in one. Five patients developed segmental infarction as a
result of accessory renal artery exclusion. Of these patients,
only one developed significant hypertension; this resolved
within 3 months, similar to our own findings. They too
noted that serum creatinine remained unchanged during
follow-up (mean, 11.5months) in patients whose accessory
renal arteries had been covered during EVAR. Kim et al5
reported experience with coverage of 11 accessory renal
arteries by using the AneuRx graft, also with no significant
increase in serum creatinine, hypertension, or detectable
renal infarctions.
Others have reported the lack of clinical effect associ-
ated with segmental renal infarction.6 Kaplan et al,7 in their
review of 204 patients who underwent EVAR, noted small
segmental infarcts on follow-up CT scans in less than 20%
of patients. Hypertension was not noted in their patient
population.
Our own findings and those of the others detailed
previously question the traditional teaching that accessory
renal arteries are end arteries. Sacrifice of these arteries does
not inevitably lead to renal infarction, at least such as is
detectable by CT scanning. The incidence of detectable
renal infarction is much less than that of renal accessory
artery sacrifice in all reports to date.
In an attempt to quantify the volume of renal mass
perfused by accessory renal arteries, Dorffner et al8 evalu-
ated the use of selective renal angiography and spiral CT
scanning to assess the effect of accessory renal artery sacri-
fice. The amount of renal mass supplied by the accessory
artery was measured by computed tomographic angiogra-
phy with selective injection of the accessory renal artery.
The volume of renal infarction was equal to the renal
volume perfused by the artery. The maximum amount of
renal tissue that could be safely sacrificed could not be
precisely determined, but they arbitrarily suggested safety
of coverage of accessory renal arteries that supply no more
than 32% of the total renal mass, in normotensive patients
with normal renal function.
We noted no effect on blood pressure from renal artery
coverage. Gupta and Tello9 have suggested that the acces-
sory renal arteries are a vascular anomaly with no direct
ability to cause hypertension. In their retrospective review
of 185 hypertensive patients, 45 had renal accessory arter-
ies. They found that accessory renal arteries did not play a
role as an anatomically treatable cause of hypertension. In
keeping with this, we found no discernible effect in blood
pressure in response to the coverage of accessory renal
arteries.
Renal insufficiency is a relative contraindication to
EVAR, and the causes of renal dysfunction and renal infarc-
tion after EVAR are multifactorial.10 Serum creatinine in-
creased after EVAR in only two of our patients when
accessory renal arteries were covered. Both of these had
baseline renal insufficiency, and in both instances, creati-
nine reverted to baseline in follow-up. Even in the setting of
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coverage seemed well tolerated. We continue to monitor
our patients and tailor strategies to minimize adverse renal
effects. Our routine practice in the setting of renal insuffi-
ciency and the possibility of accessory renal exclusion is to
vigorously hydrate perioperatively, use osmotic diuretics,
and decrease or avoid the use of nephrotoxic contrast, using
gadolinium for imaging studies before, during, and after
EVAR.
Although we did not note any endoleaks attributable to
accessory renal arteries, one such case has been reported by
Aquino et al.4 They described a patent accessory renal
artery that provided outflow to a distal type I attachment
leak. The accessory renal artery thrombosed after treatment
of the attachment site leak. It is unnecessary to prophylac-
tically embolize these vessels when coverage or exclusion is
planned. Coverage of accessory renal arteries by endografts
results in immediate thrombosis. Exclusion of accessory
renal arteries arising from the aneurysm sac poses little
threat of type II endoleak, because these are end arteries,
with little possibility of back bleeding.
CONCLUSION
In summary, our study and those of others suggest that
occlusion of accessory renal arteries is not associated with
clinically significant signs and symptoms of renal impair-
ment, even in patients with mild or moderate renal insuffi-
ciency. The amount of renal loss associated with sacrifice of
accessory renal arteries is difficult to determine, and the
consequences are unknown, but sacrifice of accessory renal
arteries most commonly does not lead to detectable renal
infarction, either clinically or radiographically. Our study
and those of others suggest that when segmental renal
infarction does result, it is well tolerated. In addition, we
did not find that accessory renal arteries were a cause of
endoleaks, and therefore preoperative embolization of ac-
cessory renal arteries was not necessary to prevent endoleak
after EVAR.
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Dr Kathleen J. Ozsvath (Albany, NY). Briefly, the authors did
a retrospective study of 550 patients who underwent EVAR. They
looked specifically at 35 patients who had accessory renal arteries.
Twelve endoleaks were identified. Seven patients had renal infarcts
noted on follow-up CT scans. They looked at hypertension and
creatinine in this patient population. It was found that two patients
with renal insufficiency before EVAR had an increase in their
creatinine postoperatively, which then came back to baseline.
Hypertension was not noted in the postoperative period.
You concluded that the occlusion of the accessory renal arter-
ies during EVAR is well tolerated with no significant sequelae even
in patients with pre-existing renal dysfunction. Additionally, pa-
tients tolerated postoperative renal infarction well, and type II
endoleaks were not caused by the presence of these accessoryI have several questions:
1. The incidence of type I endoleak in this series was 9%, or 3 out
of 35. Is this similar to your overall EVAR experience? When
was the type I endoleak recognized? Was it at the end of the
case or in follow-up? What did you do to treat these type I
endoleaks? And could you have missed a type II leak at the
proximal fixation site due to accessory renal arteries?
2. You say that you had no type II endoleaks due to accessory
renals. How did you document this?
3. Exactly when in the postoperative course was the creatinine
looked at? Could you have missed the rise and fall of the
creatinine to baseline, therefore missing the window during
which ATN occurred? Did you consider looking at creatinine
clearance?
JOURNAL OF VASCULAR SURGERY
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disease? Could there have been a subset of patients with the
presence of atherosclerotic renal artery disease who then had a
worse outcome postprocedurally?
5. Did you measure the diameter of the accessory renals that you
covered? We know from the open surgical literature that small
renal accessory renal arteries can be sacrificed without se-
quelae. Could it be that the accessory renals that you sacrificed
are of insignificant diameter?
6. Did you expect to see an increase in the baseline blood
pressure in patients with renal infarctions?
7. You mentioned that 100% of patients with pre-existing renal
insufficiency had worsening of their renal function postopera-
tively. Has this changed your approach to patients with acces-
sory renal arteries during EVAR in the presence of renal
dysfunction? For example, would you suggest the use of
Mucomyst, fenoldopam, or bicarbonate infusion preopera-
tively?
8. How much contrast did you use?
9. You used an assortment of endograft devices. Of those pa-
tients who developed renal insufficiency, did you look to see if
any of those patients received grafts with suprarenal fixation?
10. Lastly, youmentioned that you know of no incidence in which
an accessory renal artery caused a type II endoleak. Dr White
et al published a paper in the Journal of Endovascular Therapy
in August of 2000 describing an 81-year-old patient who
underwent EVAR, subsequently experienced rupture, and
died due to an accessory renal artery. How would you corre-
late this with your data?
Dr Karmacharya. The first question was the incidence of type
I endoleak and our overall EVAR experience. Yes, in our paper, we
had 3 type I endoleaks. This is a small study and I do not think it
reflects our total experience of type I endoleaks in our institution.
The incidence of type I endoleaks would be approximately 1% in
our series.
When was the type I recognized?We recognized type I leaks in
the OR [operating room]. We fixed the leaks using a variety of
tools, mostly a combination of stents and deployment of balloon
cuffs.
Could we have missed a type II endoleak at the proximal
fixation site due to the presence of an accessory renal artery? Yes, it
is possible. But in our study, all accessory renal arteries that we
covered thrombosed; thus, it did not contribute to an endoleak.
How do we document if there was a type II endoleak? We did
not see a type II endoleak on follow-up scans, due to an accessory
renal artery, because the accessory renal artery was covered.
The third question was when in the postoperative course was
the creatinine level elevated? Could we have missed that resolution
of the serum creatinine to baseline, therefore missing the window
during which ATN occurred? Do we consider looking at creatinine
clearance? I think that’s a very good question. Yes, we could have
missed the window, because patients were evaluated at quarterly
intervals and then annually, so indeed we could have missed a rise
in serum creatinine and ATN that resolved.
Did we consider looking at creatinine clearance? I do not have
the creatinine clearance for this presentation. However, prospec-
tive studies in the future would be useful.Did we measure the diameter of the accessory renal arteries
covered? No.
And could the renal accessory arteries you sacrifice be of
insignificant diameter? Yes, Dorffner et al reported the volumes an
accessory renal artery supplied. He used CTA arteriography to
evaluate renal mass and vascular volume and found that the size of
the renal vessel does correlate with the volume of blood supply and
that up to 32% could be sacrificed without any long-term sequelae.
But again, his study was a very small study, and I think we need
more data.
Did you expect to see a rise in baseline blood pressure in
patients with renal infarctions? No, we didn’t. Gupta and Tello
actually demonstrated that renal infarcts did not correlate with an
increase in blood pressure.
Question 7: you mentioned that 100% of those patients with
pre-existing renal insufficiency have developed worsening of their
renal function postop. Has this changed our practice? This is in
reference to our earlier article of September 11, 2001. We have
since then altered our practice. We use gadolinium. If we do have
to use renal contrast, we do so in very small amounts, about 10 to
20 cc. We would do selective renal angiography to identify the
renal vessels and not necessarily do a complete aortogram. We
hydrate the patients pre- and postoperatively.
How much contrast do we use in patients with renal insuffi-
ciency? We try to avoid contrast at all costs.
Question 9: we used an assortment of endografts. Of those
patients who developed renal insufficiency, did you look at any of
those patients who received grafts with suprarenal fixation? That’s
a very interesting question. And as a matter of fact, we have not in
this study, but we have a control study that will soon be presented
comparing the use of the PowerLink suprarenal vs infrarenal fixa-
tion. And preliminarily, I can tell you that there were no statistical
differences.
Question 10: lastly, you mentioned that no instances of acces-
sory renal artery caused a type II endoleak, and then the question
refers to Dr White’s paper that came out in August 2000 in
Endovascular Therapy where an 81-year-old patient died of a type
II leak. How do we correlate this with our finding? Well, we did
not specifically find an endoleak type II that could be attributed to
the accessory renal artery. Lacrina et al actually had found that their
type I leak was the source of a feeding accessory renal artery, which
was recognized postop, but we didn’t see that. The main thing, I
think, is to recognize your leaks and to treat them. I think that’s
what highlights that case report.
Dr Larry Scher (Bronx, NY). Since this was a retrospective
review, I’m wondering if you know if any patients were excluded
before EVAR was attempted based on the presence of accessory
renal arteries. You might have excluded patients with more signif-
icant accessory renal arteries that would skew the data.
Dr Karmacharya. Absolutely, you’re correct. But did we know
which patients were excluded based on those findings? No.
Dr Jeffrey P. Carpenter (Philadelphia, Pa). We did write a
manuscript about who can’t have a stent graft and why that
covered roughly the same time interval, and there were only 6
patients out of our entire population that was screened who were
excluded on the basis of what we thought to be an essential
accessory renal artery.Dr Scher. Thank you for that answer.
